🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled, single-dose, design...
Status
Completed
Location
Barrow Neurological Institute
Start Date
2008-08
Trial ID
NCT00728182
Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3...
Status
Completed
Location
Long Island Jewish Medical Center
Start Date
2019-10-22
Trial ID
NCT04179721
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, single-dose study i...
Status
Withdrawn
Location
Barrow Neurological Institute
Start Date
2015-11
Trial ID
NCT02056574
The ESCAPE-NA-1 study is designed to determine the safety and efficacy of t...
Status
Completed
Location
Ronald Reagan UCLA Medical Center
Start Date
2017-03-01
Trial ID
NCT02930018
Treatments Being Tested
The primary purpose of this study is to determine if a single dose of nerin...
Status
Completed
Location
St. Joseph's Hospital & Medical Center
Start Date
2020-12-06
Trial ID
NCT04462536
Treatments Being Tested
The purpose of this study is to determine whether nerinetide (NA-1) is effe...
Status
Completed
Location
Kelowna General Hospital
Start Date
2015-03-26
Trial ID
NCT02315443
Treatments Being Tested
This is a prospective, randomized, multicenter, open-label study. After mor...
Status
Unknown
Location
The Third People's Hospital of Guilin
Start Date
2014-08
Trial ID
NCT02474316
Treatments Being Tested